From the Washington Post:
“I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overuled,” [Susan F. Wood, assistant FDA commissioner for women’s health and director of the Office of Women’s Health] wrote in an e-mail to her staff and FDA colleagues.